Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

MEDP Medpace

Trading 10-29 12:12:33 EDT

685.78

-6.90

-1.00%

High690.00	Low678.52	Vol81.23K
Open687.83	D1 Closing692.68	Amplitude1.66%
Mkt Cap19.14B	Tradable Cap15.59B	Total Shares27.91M
T/O55.66M	T/O Rate0.36%	Tradable Shares22.73M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"MEDP","market":"US","secType":"STK","nameCN":"Medpace","latestPrice":685.775,"timestamp":1793290349878,"preClose":692.68,"halted":0,"volume":81231,"delay":0,"changeRate":-0.009968528036033916,"floatShares":22733663,"shares":27910600,"eps":18.032568,"marketStatus":"Trading","change":-6.905,"latestTime":"10-29 12:12:33 EDT","open":687.83,"high":690,"low":678.52,"amount":55660594.0647,"amplitude":0.016573,"askPrice":686.97,"askSize":16,"bidPrice":685.73,"bidSize":40,"shortable":3,"etf":0,"ttmEps":18.032568,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1793304000000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1470888000000,"exchange":"NASDAQ","adjPreClose":692.68,"preHourTrading":{"tag":"盘前","latestPrice":691.29,"preClose":692.68,"latestTime":"09:29 EDT","volume":322,"amount":222800.77092,"timestamp":1793280599999,"change":-1.39,"changeRate":-0.002007,"amplitude":0.025567},"postHourTrading":{"tag":"盘后","latestPrice":692.68,"preClose":692.68,"latestTime":"19:51 EDT","volume":11337,"amount":7852850.29,"timestamp":1793231481831,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.484185,"impliedVol":0.3337,"impliedVolPercentile":0.1793},"requestUrl":"/m/hq/s/MEDP/wiki","defaultTab":"wiki","newsList":[{"id":"2679157411","title":"Medpace Executive VP of Operations Susan E. Burwig Reports Sale of $13.54 Million in Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2679157411","media":"Reuters","labels":["insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2679157411?lang=en_us&edition=fundamental","pubTime":"2026-10-29 04:24","pubTimestamp":1793219079,"startTime":"0","endTime":"0","summary":"Medpace Executive VP of Operations Susan E. Burwig Reports Sale of $13.54 Million in Common SharesMedpace Holdings Executive Vice President of Operations Susan E. Burwig sold 20,000 common shares at $","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261028:nNDLMTlPk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":"Medpace Executive VP of Operations Susan E. Burwig Reports Sale of $13.54 Million in Common Shares","news_tag":"insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065169927.USD","LU2065171402.SGD","BK4588","LU2065171311.SGD","BK4585","LU2065170008.USD","BK4121","MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2678993118","title":"Medpace Holdings Price Target Raised to $670.00/Share from $600.00 by BMO Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2678993118","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2678993118?lang=en_us&edition=fundamental","pubTime":"2026-10-27 01:35","pubTimestamp":1793036100,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677903994","title":"Medpace Holdings Inc. Signals Strong Growth in Earnings Call","url":"https://stock-news.laohu8.com/highlight/detail?id=2677903994","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677903994?lang=en_us&edition=fundamental","pubTime":"2026-10-24 08:19","pubTimestamp":1792801165,"startTime":"0","endTime":"0","summary":"Medpace Holdings Inc (($MEDP)) has held its Q3 earnings call. Read on for the main highlights of the call. Medpace Holdings Inc. delivered a broadl...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/medpace-holdings-inc-signals-strong-growth-in-earnings-call?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/medpace-holdings-inc-signals-strong-growth-in-earnings-call?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677190972","title":"Medpace Holdings is Maintained at Neutral by UBS","url":"https://stock-news.laohu8.com/highlight/detail?id=2677190972","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677190972?lang=en_us&edition=fundamental","pubTime":"2026-10-24 04:11","pubTimestamp":1792786260,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/MEDP/analyst-ratings","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677313974","title":"Medpace's Bookings, Pre-Backlog Trends Support Growth Outlook, UBS Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2677313974","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677313974?lang=en_us&edition=fundamental","pubTime":"2026-10-24 02:42","pubTimestamp":1792780967,"startTime":"0","endTime":"0","summary":"Medpace  strong bookings and healthy pipeline could support revenue growth above current expectations, with management's preliminary outlook for 2027 potentially proving conservative, UBS Securities said in a note Friday.The brokerage said strong pending requests for proposals and faster growth in pre-backlog support its outlook for service fee revenue. Management expects an increase in awards in the fourth quarter and said service fee revenue growth could outpace pass-through revenue growth.UBS raised its service fee revenue growth estimates for 2027 and 2028, citing strong bookings growth and elevated pre-backlog inflows.The brokerage also highlighted the company's Cincinnati headquarters expansion as supporting organic growth, although the new facility is expected to add $20 million in operating expenses in 2027.UBS maintained a neutral rating and raised its price target to $700 from $673.Shares of Medpace were up 1.4% in Friday afternoon trading.Price: 663.45, Change: +9.49, Percen","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2065170008.USD","LU2065171311.SGD","BK4121","BK4585","BK4588","LU2065169927.USD","MEDP","SGRT","LU2065171402.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677201029","title":"UBS Adjusts Price Target on Medpace to $700 From $673, Maintains Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2677201029","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677201029?lang=en_us&edition=fundamental","pubTime":"2026-10-23 21:40","pubTimestamp":1792762819,"startTime":"0","endTime":"0","summary":"Medpace (MEDP) has an average rating of hold and mean price target of $661.83, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677269924","title":"RBC Capital Keeps Their Buy Rating on Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677269924","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677269924?lang=en_us&edition=fundamental","pubTime":"2026-10-23 20:09","pubTimestamp":1792757382,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Ryan Halsted from RBC Capital maintained a Buy rating on Medpace Holdings, with a price target of $692.00. The comp...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/rbc-capital-keeps-their-buy-rating-on-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677792187","title":"Medpace price target raised to $730 from $700 at Mizuho","url":"https://stock-news.laohu8.com/highlight/detail?id=2677792187","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677792187?lang=en_us&edition=fundamental","pubTime":"2026-10-23 19:40","pubTimestamp":1792755611,"startTime":"0","endTime":"0","summary":"Mizuho raised the firm’s price target on Medpace (MEDP) to $730 from $700 and keeps an Outperform rating on the shares. The firm cites an improved ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-price-target-raised-to-730-from-700-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-price-target-raised-to-730-from-700-at-mizuho-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677926991","title":"Medpace price target raised to $699 from $638 at Baird","url":"https://stock-news.laohu8.com/highlight/detail?id=2677926991","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677926991?lang=en_us&edition=fundamental","pubTime":"2026-10-23 19:00","pubTimestamp":1792753246,"startTime":"0","endTime":"0","summary":"Baird raised the firm’s price target on Medpace (MEDP) to $699 from $638 and keeps an Outperform rating on the shares. The firm updated its model f...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/medpace-price-target-raised-to-699-from-638-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/medpace-price-target-raised-to-699-from-638-at-baird-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677648944","title":"Medpace Holdings, Inc. : Jefferies Raises Target Price to $600 from $560","url":"https://stock-news.laohu8.com/highlight/detail?id=2677648944","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677648944?lang=en_us&edition=fundamental","pubTime":"2026-10-23 16:43","pubTimestamp":1792745030,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261023:nFWN4691OO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4121","BK4585","LU2065171311.SGD","BK4588","LU2065171402.SGD","LU2065170008.USD","MEDP","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677966549","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Perrigo Company (PRGO), Thermo Fisher (TMO) and Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677966549","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677966549?lang=en_us&edition=fundamental","pubTime":"2026-10-22 21:20","pubTimestamp":1792675207,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Perrigo Company (PRGO), Thermo Fisher (TMO) and Medpace Holdings ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-perrigo-company-prgo-thermo-fisher-tmo-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-perrigo-company-prgo-thermo-fisher-tmo-and-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1291159041.SGD","LU2720916845.USD","LU0316494557.USD","BK4121","TMED","LU2106854487.HKD","BK4533","LU0345770308.USD","LU1854103824.USD","IE00BFTCPJ56.SGD","LU2065171402.SGD","LU2089984988.USD","HRTS","LU2211814178.USD","LU1280957306.USD","LU1791710400.SGD","LU0234572021.USD","IE00B1BXHZ80.USD","LU1815333072.USD","LU1791710582.SGD","LU2468319806.SGD","HCSG","IE00B19Z8W00.USD","LU0882574055.USD","GNMX","XBI","LU0128525929.USD","LU1923622614.USD","LU1023059063.AUD","BK4007","LU0742534661.SGD","LU1917777945.USD","MEDP","LU0096362180.USD","LU1057294990.SGD","IE0009355771.USD","FMED","LU0208291251.USD","PRGO","XLV","LU2357305700.SGD","TMO","LU0342679015.USD","LABU","LU1670627923.USD","LU2764263039.SGD","LU0266013472.USD","IE00BKPKM429.USD","BK4548","LU2125909247.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677957156","title":"Deutsche Bank Adjusts Medpace Price Target to $650 From $535, Maintains Hold Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2677957156","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677957156?lang=en_us&edition=fundamental","pubTime":"2026-10-22 19:24","pubTimestamp":1792668280,"startTime":"0","endTime":"0","summary":"Medpace Holdings (MEDP) has an average rating of hold and mean price target of $624.33, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP","DB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677654957","title":"Medpace Holdings, Inc. : Deutsche Bank Raises Target Price to $650 from $535","url":"https://stock-news.laohu8.com/highlight/detail?id=2677654957","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677654957?lang=en_us&edition=fundamental","pubTime":"2026-10-22 19:20","pubTimestamp":1792668016,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nFWN468246:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2065170008.USD","BK4121","BK4588","LU2065171402.SGD","MEDP","BK4585","LU2065171311.SGD","LU2065169927.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677395529","title":"Barclays Sticks to Its Hold Rating for Medpace Holdings (MEDP)","url":"https://stock-news.laohu8.com/highlight/detail?id=2677395529","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677395529?lang=en_us&edition=fundamental","pubTime":"2026-10-22 17:39","pubTimestamp":1792661994,"startTime":"0","endTime":"0","summary":"In a report released today, Luke Sergott from Barclays maintained a Hold rating on Medpace Holdings, with a price target of $625.00. According to T...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-hold-rating-for-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/barclays-sticks-to-its-hold-rating-for-medpace-holdings-medp-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677337869","title":"France's Sartorius Stedim Biotech 9-Month Revenue up 6.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677337869","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677337869?lang=en_us&edition=fundamental","pubTime":"2026-10-22 13:20","pubTimestamp":1792646423,"startTime":"0","endTime":"0","summary":"France's Sartorius Stedim Biotech 9-month revenue up 6.5%OverviewFrance bioprocessing technology firm's 9-month revenue rose 6.5% in constant currenciesAdjusted EBITDA for 9 months increased 4.8% yr/y","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261022:nL1N46805O:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4534","LU0957791311.USD","LU1791710582.SGD","LU2264538146.SGD","GNMX","HRTS","LU2468319806.SGD","LU0316494557.USD","LU0742534661.SGD","IE00BJT1NW94.SGD","LU1988902786.USD","LU2433249047.HKD","LU2125909593.SGD","LU2360108059.USD","LU1923622291.USD","LU0342679015.USD","FMED","BK4533","LU0640476718.USD","IE0034235188.USD","IE00BQXX3D17.EUR","LU1670627923.USD","LU2211814178.USD","IE00B1BXHZ80.USD","LU2764263203.CNY","LU0528227936.USD","LU0114720955.EUR","LU0310800379.SGD","LU1064131342.USD","BK4588","LU1720051017.SGD","LU1712237335.SGD","LU1803068623.USD","LU0128525929.USD","LU2041044095.USD","IE00BQXX3F31.USD","BK4566","MEDP","LU0345770308.USD","TMED","IE00B19Z8X17.USD","TMO","BK4535","IE00BQXX3C00.GBP","LU0208291251.USD","LU1791710400.SGD","LU0251142724.SGD","LU1923621640.USD","LU2106854487.HKD","LU2125910179.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677298880","title":"Medpace Holdings, Inc. Reports Results for the Quarter Ended September 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2677298880","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677298880?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:39","pubTimestamp":1792618781,"startTime":"0","endTime":"0","summary":"Medpace Holdings, Inc. reports results for the quarter ended September 30 - Earnings SummaryMedpace Holdings, Inc.MEDP.OQreported quarterly adjusted earnings of $4.84 per share for the quarter ended S","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nL8N4672QX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","BK4121","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","BK4585","LU2065171311.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677988393","title":"Medpace Holdings Gets $1B Buyback Authorization, Reports Higher 3Q Profit","url":"https://stock-news.laohu8.com/highlight/detail?id=2677988393","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677988393?lang=en_us&edition=fundamental","pubTime":"2026-10-22 05:38","pubTimestamp":1792618680,"startTime":"0","endTime":"0","summary":"Medpace Holdings said its board approved a new $1 billion stock buyback authorization and reported a higher third-quarter profit.The authorization, which is effective through 2028, replaces a previous buyback authorization that had $527 million remaining, the company said. That authorization was effective through the end of this year.The clinical contract research organization on Wednesday also reported a profit of $137.5 million, or $4.84 a share. That compares with a profit of $111.1 million, or $3.86 a share, a year earlier. Analysts polled by FactSet were expecting a profit of $4.44 a share.Revenue rose to $716 million from $659.9 million a year prior. Analysts were expecting $714.5 million.The company guided for full-year revenue of between $2.835 billion and $2.855 billion, lifting the bottom end of the range from $2.805 billion. Analysts are projecting full-year revenue of $2.85 billion.It expects full-year earnings of between $17.97 and $18.32 a share, up from a range of $17.25","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MEDP","BK4121","LU2065169927.USD","LU2065170008.USD","LU2065171402.SGD","BK4585","LU2065171311.SGD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677076006","title":"GUIDANCE: (MEDP) Medpace Expects Full Year 2026 Revenue Range $2.84B - $2.86B, vs. FactSet Est of $2.85B","url":"https://stock-news.laohu8.com/highlight/detail?id=2677076006","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677076006?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:37","pubTimestamp":1792615060,"startTime":"0","endTime":"0","summary":"GUIDANCE: (MEDP) Medpace Expects Full Year 2026 Revenue Range $2.84B - $2.86B, vs. FactSet Est of $2.85B","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677607395","title":"Earnings Flash (MEDP) Medpace Posts Q3 EPS $4.84, vs. FactSet Est of $4.44","url":"https://stock-news.laohu8.com/highlight/detail?id=2677607395","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677607395?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:33","pubTimestamp":1792614814,"startTime":"0","endTime":"0","summary":"Earnings Flash (MEDP) Medpace Posts Q3 EPS $4.84, vs. FactSet Est of $4.44","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEDP"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677160223","title":"Medpace Q3 Revenue Rises 8.5%, Slightly Beats Analyst Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2677160223","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2677160223?lang=en_us&edition=fundamental","pubTime":"2026-10-22 04:23","pubTimestamp":1792614199,"startTime":"0","endTime":"0","summary":"Medpace Q3 revenue rises 8.5%, slightly beats analyst estimatesOverviewUS clinical research firm's Q3 revenue rose 8.5%, slightly beating analyst expectationsQ3 net income grew to $137.5 mln, with net","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261021:nL1N46715C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HRTS","LU2468319806.SGD","LU0640476718.USD","LU2089984988.USD","TMED","LU2125910336.SGD","LU2211815571.USD","LU0708994859.HKD","LU0107464264.USD","LU1983299246.USD","LU2023250504.SGD","LU2125909916.SGD","LU1791710582.SGD","LU2265009873.SGD","SG9999001176.USD","LU0689472784.USD","LU2244417387.USD","LU0312595415.SGD","LU0109391861.USD","LU0234572021.USD","LU1551013342.USD","LU0390134368.USD","TMO","BK4566","BK4504","FMED","LU0432979614.USD","LU1854104046.USD","DHR","IE00BKVL7J92.USD","MEDP","LU0345770308.USD","LU0557290698.USD","LU1917777945.USD","LU2065169927.USD","LU2092937221.SGD","LU2041044095.USD","LU0320765489.SGD","IE00BQXX3D17.EUR","LU0511384066.AUD","BK4585","GNMX","IE00BZ1G4Q59.USD","LU2125910179.SGD","IE00BFTCPJ56.SGD","LU1803068623.USD","LU0096362180.USD","LU2065171311.SGD","LU1815333072.USD","BK4548"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.medpace.com","stockEarnings":[{"period":"1week","weight":0.0456},{"period":"1month","weight":0.1246},{"period":"3month","weight":0.1978},{"period":"6month","weight":0.659},{"period":"1year","weight":0.1932},{"period":"ytd","weight":0.2333}],"compareEarnings":[{"period":"1week","weight":-0.001},{"period":"1month","weight":0.0088},{"period":"3month","weight":0.0413},{"period":"6month","weight":0.0717},{"period":"1year","weight":0.1241},{"period":"ytd","weight":0.1326}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. Medpace Holdings, Inc. was founded in 1992 and is based in Cincinnati, Ohio.","yearOnYearQuotes":[{"month":1,"riseRate":0.6,"avgChangeRate":0.006402},{"month":2,"riseRate":0.3,"avgChangeRate":-0.035449},{"month":3,"riseRate":0.7,"avgChangeRate":0.006916},{"month":4,"riseRate":0.6,"avgChangeRate":-0.007726},{"month":5,"riseRate":0.5,"avgChangeRate":0.025051},{"month":6,"riseRate":1,"avgChangeRate":0.085381},{"month":7,"riseRate":0.7,"avgChangeRate":0.142259},{"month":8,"riseRate":0.7,"avgChangeRate":0.032474},{"month":9,"riseRate":0.636364,"avgChangeRate":0.000577},{"month":10,"riseRate":0.545455,"avgChangeRate":0.062289},{"month":11,"riseRate":0.7,"avgChangeRate":0.057867},{"month":12,"riseRate":0.7,"avgChangeRate":0.025222}],"exchange":"NASDAQ","name":"Medpace","nameEN":"Medpace"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Medpace,MEDP,Medpace股票,Medpace股票老虎,Medpace股票老虎国际,Medpace行情,Medpace股票行情,Medpace股价,Medpace股市,Medpace股票价格,Medpace股票交易,Medpace股票购买,Medpace股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Medpace(MEDP),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Medpace(MEDP) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction